

1,402,507 filings since 2004 · latest accepted Nov 4, 2026, 5:30 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 28, 2026 accepted 4:07 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Aug 5, 2026 accepted 4:04 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jun 5, 2026 accepted 4:38 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 6, 2026 accepted 4:06 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 22, 2026 accepted 5:23 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 2, 2026 accepted 4:30 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 10, 2026 accepted 4:47 PM ET | VNDAVanda Pharmaceuticals Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Feb 23, 2026 accepted 7:00 AM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Feb 19, 2026 accepted 4:31 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Feb 11, 2026 accepted 4:05 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jan 8, 2026 accepted 7:09 AM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Dec 31, 2025 accepted 6:45 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Dec 4, 2025 accepted 4:39 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Nov 28, 2025 accepted 7:06 AM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Oct 29, 2025 accepted 4:08 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 1, 2025 accepted 5:10 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Jul 31, 2025 accepted 7:34 AM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 5, 2025 accepted 4:32 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 7, 2025 accepted 4:07 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 17, 2025 accepted 9:15 AM ET | VNDAVanda Pharmaceuticals Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Feb 20, 2025 accepted 4:46 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Feb 13, 2025 accepted 4:08 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jan 27, 2025 accepted 8:22 AM ET | VNDAVanda Pharmaceuticals Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 6, 2024 accepted 4:16 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 15, 2024 accepted 8:00 AM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Oct 3, 2024 accepted 5:00 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.03Bylaws / fiscal year | DocumentSEC ↗ |
Sep 19, 2024 accepted 8:10 AM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Aug 8, 2024 accepted 7:29 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified | DocumentSEC ↗ |
Jul 31, 2024 accepted 4:05 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 20, 2024 accepted 4:59 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 13, 2024 accepted 4:38 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 6, 2024 accepted 4:30 PM ET | VNDAVanda Pharmaceuticals Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 24, 2024 accepted 4:49 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
May 24, 2024 accepted 4:31 PM ET | VNDAVanda Pharmaceuticals Inc. | 8-K/A 5.07Shareholder vote | DocumentSEC ↗ |
May 20, 2024 accepted 5:26 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 8, 2024 accepted 4:06 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
May 7, 2024 accepted 4:51 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
May 3, 2024 accepted 4:02 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified | DocumentSEC ↗ |
Apr 17, 2024 accepted 5:19 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Apr 3, 2024 accepted 4:32 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Mar 7, 2024 accepted 4:31 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Feb 21, 2024 accepted 4:32 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Feb 16, 2024 accepted 4:31 PM ET | VNDAVanda Pharmaceuticals Inc. | 8-K/A 9.01Exhibits | DocumentSEC ↗ |
Feb 7, 2024 accepted 4:07 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Feb 5, 2024 accepted 4:34 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Dec 15, 2023 accepted 4:15 PM ET | VNDAVanda Pharmaceuticals Inc. | 5.03Bylaws / fiscal year | DocumentSEC ↗ |
Dec 7, 2023 accepted 5:19 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement2.01Acquisition / disposition8.01Other events | DocumentSEC ↗ |
Nov 8, 2023 accepted 4:05 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |
Aug 21, 2023 accepted 5:13 PM ET | VNDAVanda Pharmaceuticals Inc. | 8.01Other events | DocumentSEC ↗ |
Jul 27, 2023 accepted 4:06 PM ET | VNDAVanda Pharmaceuticals Inc. | 2.02Earnings release | DocumentSEC ↗ |